VASP antibody
Principal name
VASP antibody
Alternative names for VASP antibody
Vasodilator-stimulated phosphoprotein
Ncbi ID
NP_003361.1, 9606, NP_003361, NM_003370, NP_033525.2, NM_009499
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Flow Cytometry (F), Paraffin Sections (P), ELISA (detection) (E(detection)), Frozen Sections (C), EPair for Elisa (EPair)
Background of VASP antibody
The Wiskott-Aldrich syndrome (WAS) is characterized by thrombocytopeni,a eczem,a defects in cell-mediated and humoral immunity and a propensity for lymphoproliferative diseases. The syndrome is the result of a mutation in the gene encoding a proline-rich protein termed WASP. WASP has been identified as a downstream effector of Cdc42 and has been implicated in Actin polymerization and cytoskeletal organization. A distantly related protein, VASP (vasodilator-stimulated phosphoprotein), is involved in the maintenance of cytoarchitecture by interacting with Actin-like filaments. VASP shares a limited degree of homology with the amino terminus of WASP, which is frequently mutated in WAS patients. An established substrate of cAMP and cGMP dependent kinases, VASP is phosphorylated on a regulatory serine residue 157 and localizes to focal adhesions, microfilaments and highly active regions of the plasma membrane. VASP is highly expressed in human platelets and, like WASP, may play a role in cytoskeletal organization.
General readings
Barzik M., et al. (2005) J. Biol. Chem. 280:28653-28662.
Phosphospecificity: Whole cell extracts of control (co) or SNP treated human platelets were applied to SDS-PAGE and transferred to PVDF membranes. Immunoblots were probed with mab 5C6 (0.5 μg/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec).
Phosphospecificity. Whole cell extracts of control (co) or Sodium Nitroprusside (SNP) treated human platelets and extracts from control (co) or Forskolin (F) treated HepG2 cells cells were applied to SDS-PAGE and transferred to PVDF membranes. Immunoblots were probed with mab 22E11 (0.5 µg/ ml) for 1h at RT and developed by ECL (exp.time: 30 sec).
Figure 1. Immunohistochemical analysis of paraffin-embedded human tonsil carcinoma tissue, using VASP (phospho-Ser239) antibody (AP02440PU).
Figure 2. Western blot analysis of extract from NIH/3T3 cells untreated or treated with forskolin (40 μM, 30 min), using VASP antibody (AP02690PU, Line 1 and 2) and VASP (phospho-Ser239) antibody (AP02440PU, Line 3 and 4).
Immunohistochemical analysis of paraffin-embedded human tonsil carcinoma tissue using VASP antibody (AP02474PU-S; AP02474PU-N ).
Western blot analysis of extracts from NIH/3T3 cells untreated or treated with forskolin (40μM, 30min), using VASP (pSer157) antibody (AP02474PU-S; AP02474PU-N, Lane 3 and 4).
Figure 1. Immunohistochemical analysis of paraffin-embedded human tonsil carcinoma tissue, using VASP antibody AP02690PU.
Figure 2. Western blot analysis of the extracts from NIH/3T3 cells using VASP antibody AP02690PU (Lane 1 and 2) and VASP (phospho-Ser238) antibody AP02440PU (Lane 3 and 4).
Immunofluorescence staining of methanol-fixed HeLa cells using VASP antibody AP02717PU (Red).
Western Blot analysis of extracts from 293 and C6 cells using VASP antibody
Immunohistochemistry (IHC) analyzes of VASP antibody (Cat.-No.: AP06421PU-N) in paraffin-embedded human lung carcinoma tissue.
Western blot (WB) analysis of VASP antibody (Cat.-No.: AP06421PU-N) in extracts from HEK293A cells.
Western blot analysis of the extracts from NIH/3T3 cells untreated or treated with forskolin ( 40mM, 30 min ) using VASP polyclonal antibody ( Cat # PAB5624 ) .
Western blot analysis of extract from NIH/3T3 cells using VASP polyclonal antibody ( Cat # PAB5625 ) .
Immunofluorescence of purified MaxPab antibody to VASP on HeLa cell. [antibody concentration 10 ug/ml]
VASP MaxPab polyclonal antibody. Western Blot analysis of VASP expression in human spleen.
Western Blot analysis of VASP expression in transfected 293T cell line (H00007408-T01) by VASP MaxPab polyclonal antibody.Lane 1: VASP transfected lysate(41.8 KDa).Lane 2: Non-transfected lysate.
Proximity Ligation Analysis (PLA) of protein-protein interactions between VASP and ACTG1. HeLa cells were stained with anti-VASP rabbit purified polyclonal 1:1200 and anti-ACTG1 mouse monoclonal antibody 1:50. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
Western Blot analysis of VASP expression in transfected 293T cell line (H00007408-T01) by VASP MaxPab polyclonal antibody.Lane 1: VASP transfected lysate(39.80 KDa).Lane 2: Non-transfected lysate.
Western blot analysis of VASP expression in lysates from Jurkat cells ( Lane 1 ) , NIH/3T3 cells ( Lane 2 ) and rat kidney ( Lane 3 ) .
Immunohistochemistry analyzes of VASP antibody (Cat.-No.: AP20691PU-N) in paraffin-embedded human tonsil tissue.
Western blot (WB) analyzes of VASP antibody (Cat.-No.: AP20691PU-N) in extracts from A549 cells.
Immunohistochemistry analyzes of VASP antibody (Cat.-No.: AP20692PU-N) in paraffin-embedded human tonsil tissue.
Western blot (WB) analyzes of VASP antibody (Cat.-No.: AP20692PU-N) in extracts from PC12 cells.
Immunohistochemistry (IHC) analyzes of VASP antibody (Cat.-No.: AP20814PU-N) in paraffin-embedded human tonsil tissue.
Western blot (WB) analyzes of VASP antibody (Cat.-No.: AP20814PU-N) in extracts from HeLa HUVEC cells.
Immunohistochemistry (IHC) analyzes of p-VASP antibody (Cat.-No.: AP20815PU-N) in paraffin-embedded human cervix carcinoma tissue.
Western blot (WB) analyzes of p-VASP antibody (Cat.-No.: AP20815PU-N) in extracts from NIH/3T3 cells.
Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Jurkat; WB Suggested Anti-VASP Antibody. . Titration: 1.0 ug/ml. . Positive Control: Jurkat Whole Cell; VASP antibody - C-terminal region (ARP61209_P050) in Human Jurkat cells using Western Blot
Human Fetal heart; WB Suggested Anti-VASP Antibody. . Titration: 1.0 ug/ml. . Positive Control: Fetal Heart; VASP antibody - middle region (ARP61210_P050) in Human Fetal heart cells using Western Blot
Recombinant human VASP, 1-343aa, His-tagged
Immunohistochemical analysis of VASP staining in human tonsil formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Immunofluorescent analysis of VASP staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Western blot analysis of VASP expression in A549 (A); HepG2 (B); NIH3T3 (C); PC12 (D) whole cell lysates.
Immunohistochemical analysis of VASP staining in human tonsil formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Immunofluorescent analysis of VASP staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Western blot analysis of VASP expression in HEK293T (A); HepG2 (B); NIH3T3 (C); PC12 (D) whole cell lysates.
Immunohistochemical analysis of VASP (pS157) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of VASP (pS157) expression in C6 PMA-treated (A); HuvEc (B) whole cell lysates.
Anti-VASP mouse monoclonal antibody (TA502472) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VASP(RC203544).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VASP (RC203544, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VASP.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VASP monoclonal antibody.
HEK293T cells transfected with either RC203544 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VASP antibody(TA502472), and then analyzed by flow cytometry.
Anti-VASP mouse monoclonal antibody (TA502473) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VASP(RC203544).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VASP (RC203544, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VASP.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VASP monoclonal antibody.
HEK293T cells transfected with either RC203544 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VASP antibody(TA502473), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human breast tissue within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human liver tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Human endometrium tissue within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502491)
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VASP monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VASP (RC203544, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VASP.
Anti-VASP mouse monoclonal antibody (TA502492) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VASP(RC203544).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VASP (RC203544, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VASP.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VASP monoclonal antibody.
HEK293T cells transfected with either RC203544 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VASP antibody(TA502492), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Immunohistochemical staining of paraffin-embedded Human endometrium tissue within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Immunohistochemical staining of paraffin-embedded Human lymph node tissue within the normal limits using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-VASP mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502647)
Anti-VASP mouse monoclonal antibody (TA502647) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VASP(RC203544 ).
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VASP monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VASP (RC203544, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VASP.
Flow cytometric Analysis of Hela cells, using anti-VASP antibody(TA502647),(Red), compared to a nonspecific negative control antibody(TA50011),(Blue).
HEK293T cells transfected with either RC203544 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VASP antibody(TA502647), and then analyzed by flow cytometry.
Flow cytometric Analysis of Jurkat cells, using anti-VASP antibody(TA502647),(Red), compared to a nonspecific negative control antibody(TA50011),(Blue).
Western blot analysis of VASP (pS238) expression in A549 (A); Raw264.7 (B) whole cell lysates.
Immunohistochemical analysis of VASP (pS238) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugad compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Predicted band size: 40 kDa . Positive control: 293 and C6 cells lysate. Recommended dilution: 1/ 500-1000. (Gel: 10%SDS-PAGE Lane1,2: 293 and C6 cells lysate Lysates: 30 ug per lane Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
Predicted cell location: Cytoplasm. Positive control: Hela cells. Recommended dilution: 1/ 100-200.The image is immunofluorescence of methanol-fixed Hela cells using VASP antibody at dilution 1/100. (Original magnification:×200)
Western blot analysis of VASP expression in NIH-3T3 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
Western blot analysis of VASP expression in NIH-3T3 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
HepG2 cell extract was resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit anti-VASP antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
TA348942 (0.01 ug/ml) staining of Human Platelets lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
TA348943 (0.1 ug/ml) staining of Human Platelets lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
HepG2 cell extract was resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit anti-VASP antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Western blot analysis of extracts from C6 cells untreated or treated with PMA using Phospho-VASP-S157 antibody.
Western blot analysis of extracts from serum-treated 293 and PMA-treated C6 cells, using phospho-VASP-S239 antibody.
Western blot analysis of VASP phosphorylation expression in NIH-3T3 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
Western blot analysis of VASP phosphorylation expression in PMA treated HeLa whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
Predicted band size: 40 kDa . Positive control: Serum-treated 293 and PMA-treated C6 cells lysate. Recommended dilution: 1/ 500-1000. (Gel: 10%SDS-PAGE Lane1,3: Serum-untreated 293 and PMA-untreated C6 cells lysate Lane2,4: Serum-treated 293 and PMA-treated C6 cells lysate Lysates: 30 ug per lane lysate Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
Predicted cell location: Cytoplasm. Positive control: Human tonsil carcinoma tissue. Recommended dilution: 1/ 50-100 The image on the left is immunohistochemistry of paraffin-embedded human tonsil carcinoma tissue using VASP (Phospho-Ser239) antibody at dilution 1/50, on the right is treated with the synthetic peptide. (Original magnification:x200)
Western blot analysis of the extracts from RAW264.7 cells, using VASP (Phospho-Ser238) antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human tonsil tissue, using VASP (Phospho-Ser238) antibody.The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from NIH-3T3 cells treated with forskolin 40 muM 30', using VASP (Phospho-Ser157) Antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human tonsil tissue, using VASP (phospho-Ser157) antibody.The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from HeLa, using VASP (Phospho-Ser157) Antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma using VASP (Phospho-Ser157) Antibody.The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from NIH/3T3 cells untreated or treated with forskolin (40uM, 30min), using VASP antibody (Lanes 1 and 2) and VASP (phospho-Ser238) antibody (Lanes 3 and 4).
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using VASP (phospho-Ser258) antibody.
- Quick-Filters:
- Cited (2)
- Highly Validated (5)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA502473 | VASP antibody |
||||||
| VASP mouse monoclonal antibody, clone OTI1H8 (formerly 1H8) | |||||||
 |
Mouse | IgG1 | OTI1H8 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Top Selling product! Highly validated antibody!
|
||||||
| AM00155BT-N | VASP pSer157 antibody |
||||||
 |
Mouse | IgG1 | 5C6 | Biotin | Hu, Ms | E, F, ICC/IF, IP, WB |
0.1 mg /
€530.00
|
| OriGene Technologies GmbH | |||||||
Published recently! |
|||||||
| AM00155PU-N | VASP pSer157 antibody |
||||||
 |
Mouse | IgG1 | 5C6 | Purified | Hu, Ms | E, F, ICC/IF, IP, WB |
0.1 mg /
€470.00
|
| OriGene Technologies GmbH | |||||||
Published recently! |
|||||||
| TA502472 | VASP antibody |
||||||
| VASP mouse monoclonal antibody, clone OTI2G1 (formerly 2G1) | |||||||
 |
Mouse | IgG1 | OTI2G1 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA502491 | VASP antibody |
||||||
| VASP mouse monoclonal antibody, clone OTI1F3 (formerly 1F3) | |||||||
 |
Mouse | IgG1 | OTI1F3 | Purified | Can, Hu | P, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +8 additional images |
Highly validated antibody!
|
||||||
| TA502492 | VASP antibody |
||||||
| VASP mouse monoclonal antibody, clone OTI1C3 (formerly 1C3) | |||||||
 |
Mouse | IgG1 | OTI1C3 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA502647 | VASP antibody |
||||||
| VASP mouse monoclonal antibody, clone OTI4D6 (formerly 4D6) | |||||||
 |
Mouse | IgG1 | OTI4D6 | Purified | Hu, Rt | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +11 additional images |
Highly validated antibody!
|
||||||
| TA309992 | VASP antibody |
||||||
| Rabbit anti-VASP (Phospho-Ser238) polyclonal antibody(Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€353.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA312097 | VASP antibody |
||||||
| Rabbit polyclonal VASP (Ser157) antibody(Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | E, P, WB |
0.1 ml /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA312099 | VASP antibody |
||||||
| Rabbit polyclonal VASP (Ser157) antibody(Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA312100 | VASP antibody |
||||||
| Rabbit polyclonal VASP (Ser238) antibody(Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA321572 | VASP antibody |
||||||
| Anti-VASP (Phospho-Ser239) Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA321574 | VASP antibody |
||||||
| Anti-VASP Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Rt | ICC/IF, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA325963 | VASP antibody |
||||||
| Rabbit Polyclonal VASP Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA325964 | VASP antibody |
||||||
| Rabbit Polyclonal VASP Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA325965 | VASP antibody |
||||||
| Rabbit Polyclonal VASP (Ser157) Antibody (Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA325966 | VASP antibody |
||||||
| Rabbit Polyclonal VASP (Ser238) Antibody (Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA327971 | VASP antibody |
||||||
| Rabbit Polyclonal anti-VASP Antibody | |||||||
 |
Rabbit | IgG | Poly6156 | Purified | Hu, Ms | WB |
0.2 ml /
€335.00
|
| OriGene Technologies, Inc. | |||||||
| TA333056 | VASP antibody |
||||||
| Phospho-VASP-S239 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA333080 | VASP antibody |
||||||
| Phospho-VASP-S157 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
